Equity
€236,930 ▲ 151%
Equity rose in 2025 from €94,403 to €236,930.
KLINIKO
Lifetime
2 annual accounts with figures on one time axispeak €195,647 (2025)
€195,647▲ 49.3%
peak €142,526 (2025)
€142,526▲ 53.7%
peak €236,930 (2025)
€236,930▲ 151%
€59,915▲ 31.9%
Board1 name since 2023
1 director
Documentsfilings and deeds
20-12-202542 days before the deadline
2025micro format
Gross margin from €131,078 to €195,647Result from €92,703 to €142,526Equity from €94,403 to €236,930Debts from €45,431 to €59,915Investments €8,891
Key points
from the 2025 annual accountsInvestments
€8,891 5.3 × depreciation
Green is investment, beige is depreciation.
Liquidity
4.78 was 3.01 in 2024
Short-term debts rose from €45,431 to €59,915.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as KLINIKO has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for KLINIKO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0802217912
Incorporation
Founding capital of €2,500, 100 shares · Founder: (comparant) · Appointment: (director) · published on 01-06-2023 · Gazette deed
First establishment
Theophiel Van der Cruyssenhof 2, Lochristi
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| KLINIKO Lochristi | €296,845 | €195,647 | 79.8% | - |
| Verocq Consult Lierde | €341,934 | €189,300 | 87.0% | - |
| Dr. Jolien De Meyer, urgentiegeneeskunde Gavere | €334,299 | €182,413 | 94.4% | - |
| Dokter Pauline Lemmens Antwerp | €302,835 | €198,702 | 78.2% | - |
| Jonathan Diego Baragaño Andenne | €316,580 | €187,147 | 79.9% | - |
| MedEase Anesthesia Mouscron | €310,103 | €202,353 | 3.3% | - |
| ANAPPEL Ledegem | €312,316 | €194,112 | 78.7% | - |
These companies have the same main activity as KLINIKO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €303,000 and €342,000, founded in 2023.
Official details
Source: KBO- Status
- Active since 30-05-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220and 2 others
- Establishment unit
- 2.345.969.1509080 Lochristi, since 30-05-2023
- Financial year end
- 30 June
- Peppol
- Reachable since 26-10-2024
Annual accounts to 30-06-2025
- ≈ €360,000estimated
- €296,845▲ 112%
- Filing
- Filed on 20-12-2025, 42 days before the end of the filing period
Insights on KLINIKO
KLINIKO has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €236,930 and a net result of €142,526.
Its solvency ranks better than 70% of 21,334 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about KLINIKO
- What is the company number of KLINIKO?
- The company number of KLINIKO is 0802.217.912. The VAT number is the same number with BE in front: BE 0802.217.912.
- Where is KLINIKO based?
- The registered office is at Theophiel Van der Cruyssenhof 2, 9080 Lochristi.Company details
- What does KLINIKO do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of KLINIKO?
- KLINIKO is a private limited company (BV).
- When was KLINIKO founded?
- KLINIKO was founded on 30-05-2023.
- Is KLINIKO still active?
- Yes, KLINIKO is an active enterprise in the KBO register.
- What is the turnover of KLINIKO?
- The turnover in financial year 2025 is ≈ €360,000. This figure is estimated from the gross margin of €195,647 and 40 comparable companies (NACE 86220). It probably lies between €310,000 and €480,000.Financials
- Is KLINIKO profitable?
- In financial year 2025, KLINIKO made a profit of €142,526.
- Where can I find the annual accounts of KLINIKO?
- KLINIKO filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of KLINIKO due?
- KLINIKO must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.